We are live on
!
Find out more
Zurich Cantonal Bank Portfolio holdings
AUM
$46B
1-Year Est. Return
27.59%
This Fund
S&P 500
This Quarter
Est. Return
+10.62%
1 Year Est. Return
+27.59%
3 Year Est. Return
+97.89%
5 Year Est. Return
+132.69%
10 Year Est. Return
+500.34%
AUM
$43.5B
AUM Growth
+$2.64B
(+6.4%)
Cap. Flow
-$751M
Cap. Flow
% of AUM
-1.72%
Top 10 Holdings %
Top 10 Hldgs %
35.47%
Holding
2,607
New
56
Increased
1,180
Reduced
588
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$172M |
| 2 |
Tesla
TSLA
|
+$117M |
| 3 |
Oracle
ORCL
|
+$60.5M |
| 4 |
CVS Health
CVS
|
+$60.1M |
| 5 |
Carpenter Technology
CRS
|
+$40.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$263M |
| 2 |
Microsoft
MSFT
|
+$98.2M |
| 3 |
NVIDIA
NVDA
|
+$68.4M |
| 4 |
McDonald's
MCD
|
+$66.2M |
| 5 |
UnitedHealth
UNH
|
+$60.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.02% |
| 2 | Financials | 17.25% |
| 3 | Consumer Discretionary | 9.83% |
| 4 | Healthcare | 9.66% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Rocket Pharmaceuticals
RCKT
$388M
| $14.2K | ﹤0.01% |
4,345
-24,125
| -85% | -$76K |
|
2427
AbCellera Biologics
ABCL
$2.82B
| $13.2K | ﹤0.01% |
2,633
-1,156
| -31% | -$5.09K |
|
2428
Rigel Pharmaceuticals
RIGL
$765M
| $13.1K | ﹤0.01% |
461
-202
| -30% | -$6.04K |
|
|
SCPH
2429
DELISTED
scPharmaceuticals
SCPH
| $13K | ﹤0.01% |
+2,300
| New | +$11.8K |
|
2430
Theravance Biopharma
TBPH
$876M
| $12.7K | ﹤0.01% |
868
-378
| -30% | -$4.78K |
|
|
LENZ
2431
LENZ Therapeutics
LENZ
$171M
| $12.4K | ﹤0.01% |
267
-129
| -33% | -$4.74K |
|
2432
Hyster-Yale Materials Handling
HY
$643M
| $12.4K | ﹤0.01% |
336
| – | – |
|
|
CNTA
2433
DELISTED
Centessa Pharmaceuticals
CNTA
| $11.7K | ﹤0.01% |
481
-201
| -29% | -$3.57K |
|
2434
GlobalFoundries
GFS
$28B
| $11.2K | ﹤0.01% |
312
+46
| +17% | +$1.64K |
|
2435
Ascendis Pharma A/S
ASND
$16.8B
| $11.1K | ﹤0.01% |
56
-27
| -33% | -$5.04K |
|
|
OTLY
2436
Oatly Group
OTLY
$420M
| $10.5K | ﹤0.01% |
651
-15
| -2% | -$242 |
|
2437
MeiraGTx Holdings
MGTX
$1.21B
| $10.4K | ﹤0.01% |
1,269
-572
| -31% | -$4.52K |
|
2438
American Public Education
APEI
$917M
| $10.3K | ﹤0.01% |
260
-221
| -46% | -$7.01K |
|
|
PONY
2439
Pony AI Inc
PONY
$3.7B
| $10.1K | ﹤0.01% |
+449
| New | +$6.83K |
|
|
LKFT
2440
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.81B
| $9.73K | ﹤0.01% |
281
-128
| -31% | -$4.09K |
|
2441
argenx
ARGX
$54.2B
| $9.59K | ﹤0.01% |
13
-6
| -32% | -$3.96K |
|
|
ESPR
2442
DELISTED
Esperion Therapeutics
ESPR
| $9.26K | ﹤0.01% |
3,496
-2,586
| -43% | -$5K |
|
2443
Design Therapeutics
DSGN
$899M
| $9.24K | ﹤0.01% |
1,227
-590
| -32% | -$2.96K |
|
|
WRD
2444
WeRide Inc
WRD
$2.1B
| $8.86K | ﹤0.01% |
+895
| New | +$8.48K |
|
2445
Zegna
ZGN
$3.8B
| $8.81K | ﹤0.01% |
932
| – | – |
|
2446
Summit Therapeutics
SMMT
$11.9B
| $8.76K | ﹤0.01% |
424
-204
| -32% | -$4.95K |
|
2447
Zevra Therapeutics
ZVRA
$682M
| $8.71K | ﹤0.01% |
916
-403
| -31% | -$4.04K |
|
2448
Personalis
PSNL
$1.52B
| $8.25K | ﹤0.01% |
1,265
-562
| -31% | -$3.2K |
|
2449
Monte Rosa Therapeutics
GLUE
$1.34B
| $7.81K | ﹤0.01% |
1,054
-506
| -32% | -$2.68K |
|
2450
Mercer International
MERC
$34.5M
| $7.34K | ﹤0.01% |
2,549
| – | – |
|
Similar funds
LP
TI
Zurich Cantonal Bank's Q3 2025 Portfolio in Review
As of Q3 2025, Zurich Cantonal Bank held 2,607 positions worth $43.5B, up 6.4% from $40.9B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 4.4%. Zurich Cantonal Bank opened 56 new positions and exited 58, leaving the 2,607-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
- Zurich Cantonal Bank's largest Q3 2025 buy was Paramount Skydance Corp: 139,876 shares worth $2.65M.
- Zurich Cantonal Bank added most to Bank of America in Q3 2025, an estimated $172M increase.
- Zurich Cantonal Bank's biggest Q3 2025 reduction was UBS Group, cutting an estimated $263M.
- Zurich Cantonal Bank fully exited Ansys in Q3 2025, selling an estimated $18.3M.
- Zurich Cantonal Bank's ten largest holdings make up 35% of its $43.5B portfolio in Q3 2025.
- Zurich Cantonal Bank opened 56 new positions and closed 58 in Q3 2025.
- Zurich Cantonal Bank's portfolio value rose 6.4% quarter-over-quarter to $43.5B.
Based on Zurich Cantonal Bank's 13F filing for Q3 2025, filed 14 Nov 2025.